Intravenous Levetiracetam for Treatment of Neonatal Seizures
Overview
Affiliations
In this case series we report on eight neonates with refractory seizures who received intravenous levetiracetam when seizures did not respond to two or more conventional anticonvulsants. Six of the eight neonates had an excellent response with either cessation, or reduction in seizures by at least 80%. One neonate showed a partial response while one did not have any reduction in seizure frequency. We did not encounter any adverse effects that could be attributable to levetiracetam.
Efficacy of Levetiracetam as Add-On Therapy in the Treatment of Seizures in Neonates.
Rondagh M, de Vries L, Peeters-Scholte C, Tromp S, Steggerda S Neonatology. 2023; 121(2):233-243.
PMID: 38113859 PMC: 10994567. DOI: 10.1159/000535499.
Massey S, Glass H, Shellhaas R, Bonifacio S, Chang T, Chu C J Pediatr. 2021; 242:63-73.
PMID: 34728234 PMC: 8882137. DOI: 10.1016/j.jpeds.2021.10.058.
Falsaperla R, Scalia B, Giugno A, Pavone P, Motta M, Caccamo M Ital J Pediatr. 2021; 47(1):85.
PMID: 33827647 PMC: 8028713. DOI: 10.1186/s13052-021-01027-2.
Yi Z, Zhong X, Wang M, Zhang Y, Zhai S Front Pharmacol. 2020; 11:751.
PMID: 32670054 PMC: 7326124. DOI: 10.3389/fphar.2020.00751.
Intravenous Levetiracetam for Treatment of Seizures in Term and Preterm Neonates.
Karaoglu P, Hiz S, Iscan B, Polat A, Ayanoglu M, Duman N J Pediatr Neurosci. 2020; 15(1):15-20.
PMID: 32435300 PMC: 7227750. DOI: 10.4103/JPN.JPN_66_19.